Marshall Wace’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Marshall Wace’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,378,941	Closed	-$13.8M	–	3855
2022 Q3	$13.8M	Hold	1,378,941	–	–	0.03%	643
2022 Q2	$13.6M	Hold	1,378,941	–	–	0.03%	669
2022 Q1	$13.6M	Hold	1,378,941	–	–	0.03%	668
2021 Q4	$13.5M	Buy	1,378,941 +749,994	+119%	+$7.39M	0.03%	670
2021 Q3	$6.17M	Buy	+628,947	New	+$6.19M	0.03%	821

Marshall Wace's LUXA Position: Q4 2022 in Review

Marshall Wace sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 1,378,941 shares — an estimated $13.8M sold.

Marshall Wace first reported a position in LUXA in Q3 2021 and held it in 5 quarters. The position peaked at $13.8M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Marshall Wace reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 1,378,941 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $13.8M.
Marshall Wace first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 5 quarters.
Marshall Wace's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $13.8M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.